- Home
- MDXG vs REAL Comparison
MDXG vs REAL Comparison
Compare MDXG & REAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXG
- REAL
- Stock Information
- Founded
- MDXG 2006
- REAL 2011
- Country
- MDXG United States
- REAL United States
- Employees
- MDXG N/A
- REAL N/A
- Industry
- MDXG Biotechnology: Pharmaceutical Preparations
- REAL Other Specialty Stores
- Sector
- MDXG Health Care
- REAL Consumer Discretionary
- Exchange
- MDXG Nasdaq
- REAL Nasdaq
- Market Cap
- MDXG 1.3B
- REAL 1.2B
- IPO Year
- MDXG N/A
- REAL 2019
- Fundamental
- Price
- MDXG $8.57
- REAL $9.30
- Analyst Decision
- MDXG Strong Buy
- REAL Buy
- Analyst Count
- MDXG 5
- REAL 6
- Target Price
- MDXG $12.00
- REAL $7.04
- AVG Volume (30 Days)
- MDXG 617.6K
- REAL 2.9M
- Earning Date
- MDXG 02-26-2025
- REAL 02-27-2025
- Dividend Yield
- MDXG N/A
- REAL N/A
- EPS Growth
- MDXG N/A
- REAL N/A
- EPS
- MDXG 0.52
- REAL N/A
- Revenue
- MDXG $342,804,000.00
- REAL $579,862,000.00
- Revenue This Year
- MDXG $9.56
- REAL $11.27
- Revenue Next Year
- MDXG $9.19
- REAL $9.11
- P/E Ratio
- MDXG $16.49
- REAL N/A
- Revenue Growth
- MDXG 10.93
- REAL 2.52
- 52 Week Low
- MDXG $5.47
- REAL $1.52
- 52 Week High
- MDXG $10.14
- REAL $11.38
- Technical
- Relative Strength Index (RSI)
- MDXG 41.31
- REAL 49.63
- Support Level
- MDXG $8.29
- REAL $8.65
- Resistance Level
- MDXG $9.30
- REAL $10.14
- Average True Range (ATR)
- MDXG 0.30
- REAL 0.54
- MACD
- MDXG -0.04
- REAL -0.12
- Stochastic Oscillator
- MDXG 27.10
- REAL 26.17
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
About REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the us, generating $1.7 billion in 2023 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 34% of net merchandise value, which excludes returns, cancellations, and first-party sales.